More Mega-Mergers in Big Pharma

Merck (MRK) announced that it's buying Schering-Plough (SGP) for $41 billion. This was only the latest big buyout in the world of major pharmaceutical companies, and I expect more to come.

Once Pfizer (PFE) made its move for Wyeth (WYE), Merck simply had to respond. continued

by Louis Navellier | 03/16/09 | Stocks: ABT, AMGN, BMY, DNA, MRK, PFE, SGP, WYE,

Post a Comment

blog comments powered by Disqus

DJIA	10,095.90	187.51	1.89%
NASDAQ	2,154.31	28.26	1.33%
S&P 500	1,072.27	15.53	1.47%


	Can Citigroup Be Saved? Citigroup Inc. (C) announced that it is making plans to planning to increase the number of its common shares outstanding and execute a reverse stock split as part of its effort to convert preferred shares to common shares. Citi is seeking to exchange about $27.5 billion in public and private preferred securities as part of its agreement with the Treasury Department, which has pledged to match up to $25 billion of the conversions. This deal represents the government's third attempt... continue

Get Our RSS Feeds

Subscribe to our RSS feed and you will receive all the articles by InvestorPlace Blogs contributors. Each contributor has their own RSS feed on their blog if you want to just follow specific people.

More Mega-Mergers in Big Pharma

Post a Comment

Can Citigroup Be Saved?

Get Our RSS Feeds